Profile data is unavailable for this security.
About the company
Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The Company offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has over 32 additional generic prescription drugs. In addition, the Company is conducting a proprietary drug development program which consists of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). It also operates two wholly owned subsidiaries: NoraPharma Inc., which has a portfolio of pharmaceutical products consisting of approximately 61 generic prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells non-prescription over-the-counter (OTC) products.
- Revenue in USD (TTM)30.48m
- Net income in USD-3.68m
- Incorporated2006
- Employees44.00
- LocationSunshine Biopharma Inc333 Las Olas Way, Cu4 Suite 433FORT LAUDERDALE 33301United StatesUSA
- Phone+1 (954) 515-0810
- Fax+1 (514) 426-6101
- Websitehttps://www.sunshinebiopharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SOHM Inc | -100.00bn | -100.00bn | 2.29m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Vestiage Inc | 0.00 | -39.63k | 2.32m | 0.00 | -- | -- | -- | -- | -0.0007 | -0.0007 | 0.00 | -0.0015 | 0.00 | -- | -- | -- | -12,384.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -102.30 | -- | -- | -- |
Scorpius Holdings Inc | 9.85m | -29.57m | 2.34m | 82.00 | -- | 0.0144 | -- | 0.2374 | -183.17 | -200.56 | 53.89 | 51.92 | 0.1552 | -- | 11.08 | 120,061.60 | -49.90 | -39.37 | -59.65 | -43.18 | 64.27 | -- | -321.53 | -1,068.21 | 0.3127 | -43.94 | 0.3569 | -- | 1,789.58 | 3.84 | 1.96 | -- | 27.32 | -- |
Altamira Therapeutics Ltd | 59.60k | -224.50k | 2.40m | 10.00 | 0.9355 | 0.2684 | -- | 40.26 | 0.6788 | 0.6788 | 0.0337 | 2.37 | 0.008 | -0.1997 | 3.36 | 5,960.18 | -2.99 | -66.27 | -5.77 | -113.27 | 150.61 | -- | -376.67 | -25,125.90 | 0.4268 | -- | 0.0634 | -- | -- | -- | 89.86 | -- | -- | -- |
Shuttle Pharmaceuticals Holdings Inc | 0.00 | -7.20m | 2.43m | 8.00 | -- | 0.3581 | -- | -- | -10.29 | -10.29 | 0.00 | 3.04 | 0.00 | -- | -- | 0.00 | -123.53 | -- | -147.27 | -- | -- | -- | -- | -- | -- | -4.32 | 0.5076 | -- | -- | -- | -112.71 | -- | -- | -- |
Nexien Biopharma Inc | 0.00 | -246.18k | 2.89m | 0.00 | -- | -- | -- | -- | -0.0038 | -0.0038 | 0.00 | -0.0048 | 0.00 | -- | -- | -- | -679.40 | -860.53 | -- | -1,653.53 | -- | -- | -- | -- | -- | -1.77 | -- | -- | -- | -- | 42.22 | -- | -- | -- |
Sonnet Biotherapeutics Holdings Inc | 55.89k | -7.99m | 3.17m | 12.00 | -- | 1.22 | -- | 56.78 | -24.17 | -24.17 | 0.1156 | 4.01 | 0.0071 | -- | 0.0881 | 4,657.50 | -100.88 | -- | -255.30 | -- | -- | -- | -14,287.67 | -- | -- | -331.07 | 0.00 | -- | -57.76 | -- | 36.64 | -- | -- | -- |
Sunshine Biopharma Inc | 30.48m | -3.68m | 3.31m | 44.00 | -- | 0.1466 | -- | 0.1084 | -194.01 | -194.01 | 1,017.85 | 20.07 | 1.06 | 3.33 | 10.19 | 692,772.50 | -12.75 | -101.52 | -15.41 | -137.04 | 30.41 | 35.47 | -12.07 | -165.33 | 3.26 | -- | 0.00 | -- | 454.42 | -- | 83.15 | -- | 110.99 | -- |
Aoxing Pharmaceutical Company Inc | 30.11m | -1.46m | 3.45m | 339.00 | -- | 0.0403 | -- | 0.1145 | -0.0192 | -0.0192 | 0.3951 | 0.2507 | 0.496 | 2.32 | 2.56 | -- | -2.41 | -14.54 | -7.06 | -35.45 | 76.19 | 68.51 | -4.85 | -37.69 | 0.7368 | 0.3387 | 0.6052 | -- | 26.88 | 37.20 | -62.49 | -- | -38.80 | -- |
Sonoma Pharmaceuticals Inc | 12.70m | -4.56m | 3.57m | 172.00 | -- | 0.51 | -- | 0.2815 | -10.07 | -10.07 | 20.98 | 5.24 | 0.859 | 2.91 | 4.47 | 73,831.40 | -30.85 | -29.36 | -41.88 | -40.65 | 38.17 | 38.00 | -35.91 | -30.93 | 2.47 | -- | 0.0394 | -- | -4.05 | -7.66 | 6.13 | -- | -29.84 | -- |
Sentient Brands Holdings Inc | 0.00 | -954.07k | 3.73m | 2.00 | -- | -- | -- | -- | -0.0164 | -0.0164 | 0.00 | -0.0307 | 0.00 | 0.00 | -- | 0.00 | -460.67 | -220.36 | -- | -- | -- | 41.81 | -- | -31,451.19 | 0.0015 | -2.50 | -- | -- | -73.68 | -- | 34.98 | -- | -- | -- |
Evoke Pharma Inc | 7.53m | -6.53m | 4.09m | 4.00 | -- | 1.54 | -- | 0.5439 | -16.23 | -16.23 | 11.24 | 3.63 | 0.7128 | 0.4307 | 4.97 | 1,881,428.00 | -61.83 | -100.48 | -136.53 | -151.10 | 96.97 | -- | -86.75 | -480.52 | 1.22 | -19.91 | 0.6523 | -- | 106.51 | -- | 5.25 | -- | -- | -- |
Processa Pharmaceuticals Inc | 0.00 | -10.22m | 4.10m | 13.00 | -- | 0.6001 | -- | -- | -5.36 | -5.36 | 0.00 | 2.10 | 0.00 | -- | -- | 0.00 | -115.58 | -84.35 | -133.48 | -90.03 | -- | -- | -- | -- | -- | -- | 0.0016 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
China Pharma Holdings Inc | 6.25m | -4.40m | 4.12m | 231.00 | -- | 0.5562 | -- | 0.6595 | -0.6254 | -0.6254 | 0.6379 | 0.4317 | 0.417 | 2.34 | 23.57 | 27,047.32 | -29.39 | -29.66 | -59.89 | -55.25 | -25.89 | 6.47 | -70.48 | -73.09 | 0.2449 | -21.22 | 0.3494 | -- | -13.48 | -10.68 | 22.50 | -- | -25.78 | -- |
Tian'an Pharmaceutical Co Ltd | 10.65m | 3.14m | 4.24m | -- | 0.0236 | 0.0051 | 1.16 | 0.3981 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
L1 Capital Global, Inc.as of 13 Feb 2024 | 52.86k | 0.28% |
Citadel Securities LLCas of 31 Mar 2024 | 5.51k | 0.03% |
Bridgeway Capital Management LLCas of 31 Mar 2024 | 2.86k | 0.02% |
Jane Street Capital LLCas of 31 Mar 2024 | 876.00 | 0.01% |
RBC Dominion Securities, Inc. (Investment Management)as of 31 Mar 2024 | 650.00 | 0.00% |
XTX Markets LLCas of 31 Mar 2024 | 537.00 | 0.00% |
Two Sigma Investments LPas of 31 Mar 2024 | 192.00 | 0.00% |
HRT Financial LLCas of 31 Mar 2024 | 181.00 | 0.00% |
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 31 Mar 2024 | 100.00 | 0.00% |
National Bank Financial, Inc.as of 30 Jun 2024 | 65.00 | 0.00% |